Juvenescence Ltd insider trades: Serina Therapeutics (SER) SEC Form 4 filings
Companies
Where Juvenescence Ltd reports to the SEC
Other SER insiders
Open-market trades in the last 12 months
About Juvenescence Ltd's insider trades
Juvenescence Ltd is a 10% owner of Serina Therapeutics (SER). It has not reported an open-market purchase or sale.
Its filings also include grants and awards (10 filings), other transactions (9 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SER insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.